Skip to main content

Find Clinical Trials

Home
Conditions
Kidney Neoplasms

Clinical trial condition

Kidney Neoplasms

Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.

710 public trials 156 recruiting studies

Refine in advanced search Browse all conditions

Kidney Neoplasms trial results

Completed

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

NCT00006864

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Northwestern Connecticut Oncology-Hematology Associates Torrington, Connecticut, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent

NCT00836745

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Pfizer Investigational Site Jaipur, India

Pfizer Investigational Site Bangalore, Karnataka, India

Pfizer Investigational Site Mumbai, Maharashtra, India

Pfizer Investigational Site New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer

NCT00053820

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Onze Lieve Vrouw Ziekenhuis Aalst Aalst, Belgium

Institut Jules Bordet Brussels, Belgium

Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium

Universitair Ziekenhuis Antwerpen Edegem, Belgium

View Trial Details

Completed

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

NCT00003585

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of New Mexico Cancer Research & Treatment Center Albuquerque, New Mexico, United States

View Trial Details

Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

NCT00876382

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Northeast Arkansas Clinic Jonesboro, Arkansas, United States

Gulfcoast Oncology Associates St. Petersburg, Florida, United States

Medical Oncology Associates of Augusta Augusta, Georgia, United States

Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States

View Trial Details

Completed

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

NCT00016237

Conditions: Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +27 more
Locations: Lombardi Cancer Center Washington D.C., District of Columbia, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

PS-341 in Treating Patients With Metastatic Kidney Cancer

NCT00025376

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Chicago Cancer Research Center Chicago, Illinois, United States

Louis A. Weiss Memorial Hospital Chicago, Illinois, United States

Cancer Care Specialists of Central Illinois, S.C. Decatur, Illinois, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

View Trial Details

Completed

Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer

NCT00100906

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer

NCT01024205

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Orchid Clinical Trials Group at Barts and the London School of Medicine and Dentistry London, England, United Kingdom

View Trial Details

Completed

Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer

NCT00492258

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Royal Bournemouth Hospital Bournemouth, England, United Kingdom

Bristol Haematology and Oncology Centre Bristol, England, United Kingdom

Queen's Hospital Burton-on-Trent, England, United Kingdom

Addenbrooke's Hospital Cambridge, England, United Kingdom

View all 39 locations

View Trial Details